Triple negative breast cancer (TNBC) comprises a heterogeneous group of tumors defined as a basal-like subtype lacking estrogen receptor alpha (ESR1), progesterone receptor (PGR), and human epidermal growth factor receptor 2 (ERBB2) (45). Here, PGR is linked to triple-negative breast carcinoma.